📢 BIONATION Speaker Announcement! BIOTECanada is pleased to announce the Minister of Innovation, Science and Industry, The Hon. François-Philippe Champagne, PC, MP, will deliver remarks at BIONATION 2024. The Minister's insights on the future of biotechnology, innovation policy, and Canada’s role in the global science landscape will set the stage for transformative discussions. Join us as we explore the intersection of science, industry, and policy at BIONATION. 📅 The deadline to register for BIONATION is quickly approaching, secure your seat by September 6th. For more information on BIONATION visit: https://lnkd.in/dUeJCWJC Stay tuned: additional speakers will be announced in the coming weeks! #BIONATION #BIONATION2024 #biotech #biotechnology #innovation #events #cdnpoli #canada #policy #investment #research
BIOTECanada
Biotechnology Research
Ottawa, Ontario 11,573 followers
Solving for today. Building for tomorrow.
About us
BIOTECanada is the national industry association voice. With over 230 member companies, the Association’s membership is representative of the broader Canadian biotech ecosystem which is national in scope and comprised of pre-commercial biotech companies, global pharma and biotech companies, investors, incubator and accelerator organizations, and academia. In the context of global population growth and corresponding climate change, food sustainability, and human health needs, the biotechnology industry plays a vital role in developing solutions to help address the resulting human health and environmental challenges.
- Website
-
http://www.biotech.ca
External link for BIOTECanada
- Industry
- Biotechnology Research
- Company size
- 11-50 employees
- Headquarters
- Ottawa, Ontario
- Type
- Nonprofit
- Founded
- 1986
Locations
-
Primary
410 Laurier Ave W
410
Ottawa, Ontario, CA
Employees at BIOTECanada
Updates
-
Congratulations to BIOTECanada President & CEO, Andrew Casey, on receiving the Anniversary Medal from Canada's Drug Agency. Presented every 5 years, the Anniversary Medals recognize individuals whose commitment and dedication have helped elevate health technology assessment as a vital component of Canada’s healthcare system. The Anniversary Medal awarded to Andrew recognizes his leadership and commitment to the principle of developing constructive and proactive working relationships with policy bodies such as Canada’s Drug Agency. The award underscores the value of the positive BIOTECanada-CDA working which will not only improve Canada’s health technology assessment capacity broadly, but most importantly, will deliver better health outcomes for Canadian patients.
Congratulations to Andrew Casey, one of the recipients of our 35th Anniversary Medals. Andrew Casey is the President and CEO of BIOTECanada, the national biotechnology industry association, and is recognized as a pragmatic and creative advocate for Canada’s life sciences sector. As a member of the Industry Liaison Forum at Canada’s Drug Agency, he has helped open doors and supported our collaboration with industry. --- Félicitations à Andrew Casey, qui a remporté une médaille 35e anniversaire. Andrew Casey est le président-directeur général de BIOTECanada, l’association nationale du domaine de la biotechnologie. Il est connu comme un porte-parole pragmatique et créatif du secteur des sciences de la vie au Canada. Membre du forum de liaison avec le secteur privé de l’Agence des médicaments du Canada, il a aidé à ouvrir des portes et appuie notre collaboration avec le secteur privé. #CDA_AMC #HTA #CdnHealth #SantéCdn
-
With 12 days to go until BIONATION, the next BIONATION Builder we're featuring is, Genome Canada. Genome Canada has embraced a mission-driven, challenge-based approach to research funding that ignites innovation and drives real-world impact. Since its inception, Genome Canada has invested more than $1.36 B in—and leveraged an additional $2.4B for—genomics research focused on improving health, protecting the environment and growing Canada’s economy. Genome Canada-funded projects have also sparked more than 131 new startup companies. Explore www.genomecanada.ca for more on Genome Canada’s impact for Canada—from precision health, to climate-smart agriculture and food systems, to bioeconomic growth. Read more about BIONATION here: https://lnkd.in/dUeJCWJC #biotechnology #ecosystem #biotech #canada #innovation #publicpolicy #cdnpoli #bionation2024 #BIONATIONBuilder #BIONATION #BIONATION2024 --- Apprenez-en plus sur le bâtisseur de BIONATION, Génome Canada! Génome Canada a adopté une approche axée sur la mission et les défis en matière de financement de la recherche, approche qui stimule l’innovation et produit des effets concrets. Depuis sa création, Génome Canada a investi plus de 1,36 milliard de dollars — et mobilisé 2,4 milliards de dollars de plus — dans la recherche en génomique axée sur l’amélioration de la santé, la protection de l’environnement et la croissance de l’économie canadienne. Les projets financés par Génome Canada ont également donné naissance à plus de 131 nouvelles entreprises en démarrage. Consultez www.genomecanada.ca/fr pour en savoir plus sur les retombées de Génome Canada sur le Canada, qu’il s’agisse de la santé de précision, de la production bioalimentaire durable et adaptée au climat, ou de la croissance bioéconomique. En savoir plus sur BIONATION ici : https://lnkd.in/dUeJCWJC
-
Congratulations to BIOTECanada member Entos Pharmaceuticals for their research published in Cell by Cell Press. Their innovative FAST-PLV platform, which enables safe and effective delivery of DNA and RNA to tissues beyond the liver, marks a major advancement in genetic medicine. This breakthrough not only opens new doors for the treatment of serious diseases but also strengthens Canada's position as a global leader in biotech innovation. Looking forward to seeing how this new era of gene therapy unfolds! #CdnBiotech #GeneticMedicine #Innovation #ScientificBreakthrough
We are proud to announce the publication of our groundbreaking research in Cell by Cell Press, demonstrating the safe and effective delivery of DNA and RNA using our FAST-PLV platform. Designed to overcome the limitations of current gene delivery technologies, FAST-PLV has the potential to fully realize the promise of genetic medicine. This milestone marks the beginning of a new era in the field and reinforces our commitment to developing safer, more effective, and re-dosable therapies for patients. The online publication is available to check out below, with the print issue live on September 19. https://lnkd.in/gmNsqAJp University of Alberta Dalhousie University Alberta Cancer Foundation BIOTECanada BioAlberta Edmonton Global #geneticmedicine #Fusogenix #PLV #groundbreaking
-
BIONATION 2024 Reaches Capacity: Thank You for Your Support On behalf of BIOTECanada, we are pleased to announce that BIONATION 2024 has reached full capacity with representation from throughout the Canadian biotechnology ecosystem. We extend thanks to all who have expressed interest in the BIONATION event, our members, stakeholders, and partners for their support of BIONATION 2024. Your engagement is pivotal in showcasing Canada’s leadership in science, discovery, and innovation, as we come together in Ottawa to highlight the biotech sector's immense potential at BIONATION 2024. For those unable to attend this year’s at-capacity event, we encourage you to stay connected. Visit our BIONATION page to explore event details, access key publications, and experience highlights from the program. We look forward to your continued involvement in the BIONATION community through these platforms. For more details, visit: https://lnkd.in/dUeJCWJC #biotechnology #ecosystem #biotech #canada #innovation #publicpolicy #cdnpoli #bionation2024 #BIONATION
-
Delighted to welcome Genome Canada as our latest BIONATION builder. The 2024 BIONATION is an important and timely opportunity for industry leaders and federal policymakers to connect as it occurs as the industry experiences significant growth and success, and the federal government continues to implement its Biomanufacturing and Life Science Strategy with investments into building Canada’s life sciences sector. Learn more about GenomeCanada here: https://genomecanada.ca/ Read more about BIONATION here: https://lnkd.in/enwkR9A2 #biotechnology #ecosystem #biotech #canada #innovation #publicpolicy #cdnpoli #bionation2024 #BIONATIONBuilder Nous sommes enchantés d’accueillir GenomeCanada au rang de nos bâtisseurs BIONATION. BIONATION 2024 représente une occasion précieuse et opportune pour les acteurs de l’industrie. Le secteur des biotechnologies connaît actuellement une croissance et un succès marqués, propulsés par la Stratégie en matière de biofabrication et de sciences de la vie du gouvernement fédéral et les investissements qui y sont associés. Apprenez-en plus sur GenomeCanada ici : https://genomecanada.ca/ Apprenez-en plus sur BIONATION ici : https://lnkd.in/enwkR9A2
-
With 26 days to go until BIONATION 2024, the next BIONATION Builder we're featuring is, AbbVie. AbbVie's mission is to discover and deliver innovative medicines that solve serious health issues today and address the medical challenges of tomorrow. They strive to have a remarkable impact on people’s lives across several key therapeutic areas: immunology, oncology, neuroscience and eye care, in addition to products and services across our Allergan Aesthetics portfolio. Read more about AbbVie here: www.abbvie.ca Read more about BIONATION here: https://lnkd.in/dUeJCWJC #biotechnology #ecosystem #biotech #canada #innovation #publicpolicy #cdnpoli #bionation2024 #BIONATIONBuilder #BIONATION #BIONATION2024
-
🎉 Celebrating the Best in Canadian Biotech! 🎉 The BIOTECanada Gold Leaf Awards celebrate the innovation and strengths fueling our biotech ecosystem. After receiving numerous nominations of outstanding individuals, companies, and organizations, we are proud to announce the 2024 winners. Their remarkable achievements will be honoured at BIONATION in September. Meet the winners: 🏆 Biotech Company of the Year: Aspect Biosystems 🏆Promising Biotech Company of the Year: Ventus Therapeutics 🏆Game-Changing Industry Leadership: Clarissa Desjardins 🏆Leadership Award: Peter Zandstra Thank you to the Gold Leaf Awards selection committee Shermaine Tilley; Maxime Pesant CPA, CFA , Geneviève Guertin, John Norman, Penny Walsh-McGuire for their dedication and thoughtful review of this year's outstanding nominees. Read more about the Gold Leaf Awards, the categories, and the winners here: https://lnkd.in/eez5Mti6
-
🚨 We're Hiring! 🚨 Are you a dynamic, organized, and outgoing professional with strong communication skills? We're looking for a Manager of Executive and Member Services to join our team for a 12-month contract! This role is pivotal in supporting our President and CEO with Board Secretariat functions, coordinating Board of Directors meetings, and managing governance work. Additionally, you’ll collaborate closely with our Senior Manager, Membership and Events to grow and engage membership, and enhance member experience at key events. If you thrive in a fast-paced environment and are passionate about making an impact, we want to hear from you! Read the full job description here: https://lnkd.in/ebqQwaBj Apply today to be part of a thriving organization driving innovation and growth in the biotech sector. 🌟 #JobOpportunity #CareerOpening #BiotechJobs #MembershipManager #ExecutiveServices
-
Delighted to once again collaborate with partners at Bio-Europe this November. By working together, we continue to strengthen and showcase Canada’s vibrant life sciences sector on a global stage. Events like these provide invaluable opportunities to connect, innovate, and drive the biotech sector forward. Looking forward to advancing groundbreaking collaborations and fostering new partnerships in Stockholm. #BiotechInnovation #LifeSciences #TeamCanada #BioEurope #Collaboration
Exciting news! At Bio-Europe 4-6 November in Stockholm, Trade & Invest British Columbia will be teaming up with BIOTECanada, Government of Canada, ONeconomy | ÉconomieON and Invest in Canada | Investir au Canada to showcase Canada’s vibrant Life Sciences sector. Bio-Europe, the premier biotechnology/pharmaceutical conference in Europe, had a record-breaking edition in Munich, Germany, in 2023. With 5,500 attendees from 65+ countries engaging in over 30,000 one-to-one meetings, the event fostered collaboration and networking with the European life sciences community. In 2023, Canada's strong presence included 120+ participants from 70+ companies/organizations. Feedback highlighted the event's exceptional value for money, focusing on partnering opportunities, high-level decision makers, and facilitating meetings at a European level. For BC companies keen on attending, a discounted ticket rate is available. Connect with me to secure your spot! Join us at Bio-Europe to explore cutting-edge advancements and expand your network in the dynamic life sciences landscape. #BioEurope #LifeSciences #Canada #Networking #Collaboration
BIO-Europe | Meet dealmakers from biotech, pharma and finance
informaconnect.com